Latest lower respiratory tract infection Stories
A study published this week in PLOS Medicine reveals profound systemic dysregulation of the immune response induced by RSV infection in young children and suggest that molecular markers might be able to predict disease severity.
Researchers have developed a new strategy for prescribing antibiotics that could reduce patient harm and help combat the rise in antibiotic resistance.
Antibiotic prescribing rates for acute respiratory tract infections could be significantly lowered using internet-based training for clinicians.
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic azithromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance.
Immunizations, including a yearly flu vaccine, are the best way to protect children from life-threatening pneumonia.
Short courses of antibiotics appear just as effective as longer ones â€” and a great deal safer â€” in treating respiratory infections that might cause pneumonia in children on temporary breathing devices.
ROCKVILLE, Md., Jan. 4, 2011 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that it has begun patient enrollment in a Phase I clinical trial to assess the safety, immunogenicity and tolerability of a vaccine candidate against respiratory syncytial virus (RSV).
Respiratory syncytial virus (RSV) causes respiratory tract infections and is a major cause of lower respiratory tract infection and hospital visits during infancy and childhood. For premature infants and infants with congenital heart disease there is a prophylactic medication. During winter months in temperate climates there is an annual epidemic. Infection in tropical climates is most common during the rainy season. 60% of infants, in the United States, are infected during their first...
- an ornament or knob in the shape of a flower